Rare diseases (RD) are diseases that affect not more than 5 per 10 000 persons (according to the EU definition). 7000 distinct rare diseases exist, affecting between 6% and 8% of the population (about 30 million EU citizens). The lack of specific health policies for rare diseases and the scarcity of the expertise, translate into delayed diagnosis, few medicinal products and difficult access to care. That is why rare diseases are a prime example of a research area that strongly profits from coordination on a European scale. At present only few European countries fund research on rare diseases through specific dedicated programmes. Therefore, the funding of transnational collaborative research is the most effective joint activity to enhance the cooperation between scientists working on rare diseases in Europe and beyond. The E-Rare consortium was built to link responsible funding bodies that combine the scarce resources and fund rare disease research via Joint Transnational Calls (JTCs). The current E-Rare-3 project proposal will extend and strengthen the transnational cooperation by building on the experience and results of the previous E-Rare-1&2 programmes. The consortium comprises 26 institutions from 17 European, Associated and non-European countries. Its international dimension will be directly translated into close collaboration with IRDiRC and other relevant European and international initiatives. IRDiRC guidelines and policies will be implemented in the four JTCs and representatives of the IRDiRC Scientific Committees will be invited to join the Advisory Board of E-Rare-3. Members of the EUCERD group will be involved in identifying rare disease research needs. Patients’ organizations from Europe (represented by EURORDIS) and beyond will be invited as a key partner towards collaborative efforts for research promotion and funding. The collaboration with European Research Infrastructures will be consolidated to enhance efficient and participative research.

Nanomedicine is the application of nanotechnology to medicine and healthcare. The field takes advantage of the physical, chemical and biological properties of materials at the nanometer scale to be used for a better understanding of the biological mechanisms of diseases at the molecular level, leading to new targets for earlier and more precise diagnostics and therapeutics. Nanomedicine, rated among the six most promising Key Enabling Technologies, is one of the most important emerging areas of health research expected to contribute to one of the strategic challenges that Europe has to face in the future: Provide effective and affordable health care and assure the wellbeing of an increasingly aged population. EuroNanoMed III (ENM III) builds on the foundations of ENM I & II, which launched 7 successful joint calls for proposals since 2009, funded 51 transnational research projects involving 269 partners from 25 countries/regions, and allocated € 45,5 million to research projects from ENM funding agencies. ENM III consortium, reinforced with 12 new partners from Europe, Canada and Taiwan, is committed to fostering the competiveness of European nanomedicine actors taking into account recent changes in the landscape and new stakeholders and challenges, as identified in the SRIA in nanomedicine. The first joint call for proposals will be co-funded by ENM III partners and the EC. After the co-funded call, three additional joint transnational calls will be organized and strategic activities will be accomplished in collaboration with key initiatives in the field. ENM III actions focus on translatability of project results to clinical and industry needs.

M-ERA.NET 3 aims at coordinating the research efforts in the participating EU Member States, Regions, and Associated States in materials research and innovation, including materials for future batteries, to support the circular economy and Sustainable Development Goals. A large network of national and regional funding organisations from 25 EU Members States, 4 Associated States and 6 countries outside Europe will implement a series of annual joint calls to fund excellent innovative transnational RTD cooperation, including one call for proposals with EU co-funding and additional non-cofunded calls. Continuing the activities started under the predecessor project M-ERA.NET 2 (3/2016-2/2021), the M-ERA.NET 3 consortium will address emerging technologies and related applications areas, such as - for example- surfaces, coatings, composites, additive manufacturing or integrated materials modelling. Research on materials supporting the large scale research initiative on future battery technologies will be particularly highlighted as a main target of the cofunded call (Call 2021) with a view to supporting in particular SDG 7 (“Affordable and clean energy”) by enabling electro mobility through sustainable energy storage technology and SDG 9 (“Industrial innovation and infrastructure”) by enhancing scientific research and upgrading the technological capabilities of industrial sectors. Several relevant action plans and initiatives will serve as programmatic guides for M-ERA.NET 3 when defining the joint activities, such as the Circular Economy Action Plan, the 2030 Agenda for Sustainable Development and its 17 Sustainable Development Goals, the EC communication “A clean planet for all”, and the “European Green Deal”. The total mobilised public call budget is expected to reach 150 million € with additional private investment of 50 million €. Thus, the leverage effect of the EU contribution will reach a factor of 13, exceeding by far the minimum required factor of 5.

SOLAR-ERA.NET Cofund will bring together 15 national organisations owning and / or managing major solar power research and innovation programmes throughout Europe, covering photovoltaics (PV) and concentrating solar power (CSP). According to the challenges addressed in the work programme on Low Carbon Energy, SOLAR-ERA.NET Cofund has different objectives: • To implement a joint call on subjects of highest priority and European added value in line with the Solar Europe Industry Initiative within the Strategic Energy Technology (SET) Plan • To pool resources and to provide critical mass for transnationally highly relevant and innovative projects • To mobilise 20 MEUR of public funding (national and EC funding), and, together with the resources provided by the private industry sector, a total of 40 MEUR. • To enhance coordination, coherence and networking between national programmes SOLAR-ERA.NET Cofund will contribute to substantial cost reductions of solar power technologies, economic development of the European solar power sector and to reinforce Europe’s strong position in solar power technologies. Reducing technology cost and advancing manufacturing technologies, applications and grid / system integration are essential to increasing the deployment of solar power technologies. This way, SOLAR-ERA.NET Cofund will greatly contribute to: • Acceleration of the time to market by advancing technologies • Affordable, cost-effective and resource-efficient technology solutions • Decarbonisation of the energy system • Sustainable, secure energy supply and completion of the energy internal market • Strengthening the European industrial technology base (growth and jobs in Europe SOLAR-ERA.NET Cofund follows on from SOLAR-ERA.NET project and network and previous PV-ERA-NET network, taking advantage of more than ten years of ERA-NET experience and expertise from all major key stakeholders in the solar research, innovation and industry sector.

The main aim of SEREN5 is to improve and professionalise the skills of the Cluster 3 (CL3) National Contact Points (NCPs) across Europe, simplifying applicants’ access to Horizon Europe (HE) calls and raising the average quality of submitted proposals. Starting from the assumption that the NCP role is crucial in order to raise the participation in HE in terms of both quality and quantity, SEREN5 overall concept is that the CL3 NCP community requires knowledge, skills, competences and a proven comprehensive suite of tools to convey a message in a multicultural and multi-disciplinary environment such the one that characterises Cluster 3 and to effectively support its broad based constituency. Therefore, the project is based on three pillars: (i) NCPs capacity building and competence development, (ii) development of targeted and high quality services (events and tools) for CL3 applicants and stakeholders , (iii) CL3 community building and general mainstreaming of CL3 NCPs in Horizon Europe.